1. Gastric mixed neuroendocrine non-neuroendocrine neoplasms
   Li Liu et al, 2024, Frontiers in Oncology CrossRef
2. CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
   Jerry B. Harvey et al, 2020, Frontiers in Immunology CrossRef
3. Immune Checkpoint Markers in Neuroendocrine Carcinoma of the Digestive System
   Jiazhang Xing et al, 2020, Frontiers in Oncology CrossRef
4. Prognostic impact of CD73 expression and its relationship to PD-L1 in patients with radically treated pancreatic cancer
   Kyösti Tahkola et al, 2021, Virchows Archiv CrossRef
5. Landscape of adenosine pathway and immune checkpoint dual blockade in NSCLC: progress in basic research and clinical application
   Rulan Wang et al, 2024, Frontiers in Immunology CrossRef
6. The Landscape and Clinical Application of the Tumor Microenvironment in Gastroenteropancreatic Neuroendocrine Neoplasms
   Shuaishuai Xu et al, 2022, Cancers CrossRef
7. Treatment personalization in gastrointestinal neuroendocrine tumors
   Chiara Borga et al, 2021, Current Treatment Options in Oncology CrossRef
8. Immunotherapy in Gastroenteropancreatic Neuroendocrine Neoplasia
   Ioana Rada Popa Ilie et al, 2023, Neuroendocrinology CrossRef
9. Gastroenteropancreatic Neuroendocrine Neoplasms (GEP NENs): The Role of Checkpoint Inhibitors
   Nicola Fazio et al, 2022, Current Cancer Drug Targets CrossRef